Cholesterol plays a tricky role in our bodies—while we need it to keep our cells healthy, too much of it can lead to serious ...

The price of prescription drugs continues to be a hot topic and last week, the U.S. Department of Health and Human Services ...

Lipid screening remains a problem for primary care physicians and pediatricians. One reason may be conflicting guidance and data.

The U.S. Centers for Medicare & Medicaid Services (CMS) has released a preliminary list of 101 generic drugs that would be ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

NHS advice indicates that too much cholesterol in one's bloodstream can escalate the risk of heart complications or stroke ...

A medical professional has shared advice on how to reduce cholesterol levels without resorting to statins. Responding to a ...

An initial list of 101 generic drugs available to those enrolled in the government's Medicare program for no more than $2 for ...

The technology also provides insight for pharmaceutical companies about how novel lipid-lowering drugs influence the cellular processes contributing to cardiovascular risk. “Over 1.5 billion people ...

Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...

Here is a list of anti-seizure medication (ASM), previously called anti-epileptic drugs or AEDs, with links to information about what type of seizures they are used for, doses, and possible side ...

AstraZeneca Plc is licensing a drug from China’s CSPC Pharmaceutical Group Ltd that it hopes will treat high cholesterol, as the pharma company seeks to bolster its cardiovascular pipeline.